ESC 365 - Audience Q&A

Open Access

Audience Q&A

Session: Early escalation for intense lipid-lowering - the ultimate game-changer for atherosclerotic cardiovascular disease (ASCVD)?

Topic: Lipids

Speaker: Doctor A. Lopez Suarez (Sevilla, Spain, ES)

Sponsored by Novartis

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ana Lopez Suarez

Complex Public Hospital Virgen del Rocio Regional, Sevilla, Spain (Spain)

5 presentations

0 follower

7 more presentations in this session

Welcome and introduction

Speaker: Doctor A. Lopez Suarez (Sevilla, Spain, ES)

The guideline gap - are we hitting the mark in post-ACS lipid management?

Speaker: Professor I. Eitel (Luebeck, DE)

Turning evidence into excellence - practical strategies for achieving Lipid-lowering therapy success post acute coronary syndrome

Speaker: Doctor A. Lopez Suarez (Sevilla, Spain, ES)

siRNA/Inclisiran and the CV continuum - are we reinventing LDL-C management?

Speaker: Doctor P. Taub (La Jolla, US)

Real-world evidence or real-world reality - Is Real world evidence a mirror or magnifier of RCTs?

Speaker: Professor P. Perrone-Filardi (Naples, IT)

Access the full session

Early escalation for intense lipid-lowering - the ultimate game-changer for atherosclerotic cardiovascular disease (ASCVD)?

Speakers: Doctor A. Lopez Suarez, Doctor A. Lopez Suarez, Professor I. Eitel, Doctor A. Lopez Suarez, Doctor P. Taub...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources